Literature DB >> 9870776

Release of immunosuppressive substances after gastric resection is more prolonged than after mastectomy in humans.

T Shirakawa1, A Tokunaga, M Onda.   

Abstract

The effects of gastric and breast cancer surgery on the systemic immune response, and potential correlations with cytokines in peritoneal fluid (PF) and wound fluid (WF) after surgery were investigated in humans. Twenty patients with gastric cancer and 13 patients with breast cancer were studied. Blood natural killer (NK) cell activity and serum soluble interleukin-2 receptor (sIL-2R) were assayed, and prostaglandin E2 and transforming growth factor-beta1 were measured in PF and WF. A prolonged decrease in NK cell activity was observed after gastrectomy compared with mastectomy. Serum sIL-2R levels were increased after gastrectomy, whereas no difference was observed after mastectomy. Cytokine levels in PF persisted on day 1 through 5 after gastrectomy, whereas in WF they dropped sharply on postoperative day 3. The systemic immune response was decreased longer after gastrectomy than mastectomy, and this immune modulation may be partly attributable to the presence of cytokines in local exudates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870776

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  3 in total

1.  Influence of major surgery on the mannan-binding lectin pathway of innate immunity.

Authors:  H Ytting; I J Christensen; L Basse; J Lykke; S Thiel; J C Jensenius; H J Nielsen
Journal:  Clin Exp Immunol       Date:  2006-05       Impact factor: 4.330

2.  Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.

Authors:  S Ben-Eliyahu; G Shakhar; K Shakhar; R Melamed
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

Review 3.  Clinical review: immunodepression in the surgical patient and increased susceptibility to infection.

Authors:  Martin K Angele; Eugen Faist
Journal:  Crit Care       Date:  2002-05-24       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.